US FDA alerts on early data suggesting potential inaccurate coronavirus test

U.S. Food and Drug Administration is alerting on early data that suggests potential inaccurate results from using the Abbott ID NOW point-of-care test to diagnose COVID-19.

Specifically, the test may return false negative results.
“This test can still be used and can correctly identify many positive cases in minutes. Negative results may need to be confirmed with a high-sensitivity authorized molecular test” 
This is the test used for the folks in the White House (and elsewhere of course).